Regulation of adipose tissue metabolism in cancer cachexia

Current Opinion in Clinical Nutrition and Metabolic Care
Chen Bing, Paul Trayhurn

Abstract

Body-fat depletion is a hallmark of cancer cachexia, a complex clinical syndrome associated with increased morbidity and mortality. Understanding the fat-loss disorder in cachexia is essential for the development of better treatments for the syndrome. This review presents recent studies focusing on the mechanisms of adipose atrophy in cancer cachexia, particularly the potential mediators. Fat loss cannot be explained by poor appetite alone, and may also result from altered lipid metabolism in adipocytes. Increased lipolysis appears to be a key factor underlying fat loss in cancer cachexia though decreases in lipid deposition and adipocyte development may also contribute. Both tumour and host-derived factors are implicated in adipose tissue atrophy. Tumour necrosis factor-alpha has been associated with increased lipolysis in adipocytes. The novel adipokine zinc-alpha2-glycoprotein may function locally, as well as systemically, to promote lipid mobilization and utilization in cancer cachexia. Clarifying the role of cachexia mediators in adipose tissue atrophy will add to our understanding of adipocyte metabolism in wasting disease. Elucidating their mode of action may lead to novel therapeutic targets for counteracting the cachex...Continue Reading

References

Jan 1, 1986·Journal of Cancer Research and Clinical Oncology·F G ShellockM C Fishbein
Oct 1, 1994·Journal of Surgical Oncology·H OgiwaraS Iida
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I Díez-ItzaC López-Otín
Jan 22, 1993·Biochimica Et Biophysica Acta·M P ThompsonJ A Tuckey
Mar 1, 1997·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M MaltoniD Amadori
Dec 24, 1997·JPEN. Journal of Parenteral and Enteral Nutrition·T YoshikawaA Matsumoto
Jun 1, 2000·Metabolism: Clinical and Experimental·K H PoldermanL J Gooren
Jul 26, 2000·Metabolism: Clinical and Experimental·S D Zuijdgeest-van LeeuwenP C Dagnelie
Mar 5, 2002·British Journal of Cancer·S T RussellM J Tisdale
Jul 2, 2003·Nutrition·Kathleen King
Dec 24, 2003·Nutrition and Cancer·Kellie A SlavieroLaurent P Rivory
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chen BingPaul Trayhurn
Jul 9, 2004·International Journal of Cancer. Journal International Du Cancer·Mohamed H ZakiMohit Trikha
Oct 8, 2004·The British Journal of Nutrition·Paul Trayhurn, I Stuart Wood
Nov 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Maria E TrujilloSusan K Fried
Aug 11, 2005·The Journal of Clinical Endocrinology and Metabolism·Ingrid DahlmanPeter Arner
Sep 22, 2005·Physiology·Michael J Tisdale
Apr 8, 2006·The American Journal of Clinical Nutrition·John E MorleyMargaret-Mary G Wilson
Jul 4, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Paul Trayhurn, Chen Bing
Jul 4, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Simona Perboni, Akio Inui
Aug 8, 2006·American Journal of Clinical Oncology·Oya KayacanDeniz Köksal
Dec 15, 2006·Nature·Evan D Rosen, Bruce M Spiegelman
Jan 20, 2007·FEBS Letters·Véronique RolliSeiamak Bahram
Apr 20, 2007·Biochemical and Biophysical Research Communications·Ann HammarstedtUlf Smith
Apr 28, 2007·Cell Death and Differentiation·W P CawthornJ K Sethi
May 18, 2007·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Richard J E SkipworthKenneth C H Fearon
Jun 5, 2007·Cancer Research·Thorhallur AgustssonPeter Arner
Jun 15, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Kamyar Kalantar-ZadehJohn E Morley

❮ Previous
Next ❯

Citations

Feb 16, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Peter van VlietRudi G J Westendorp
Aug 25, 2011·Nutrition & Metabolism·Fábio S LiraMarília Seelaender
Apr 16, 2014·Trends in Endocrinology and Metabolism : TEM·Peter Arner, Dominique Langin
Nov 14, 2012·Molecular and Cellular Neurosciences·Oscar BottassoAdriana Del Rey
May 26, 2009·Progress in Lipid Research·Max Lafontan, Dominique Langin
Aug 19, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sami AntounYohann Loriot
Apr 30, 2010·Cancer Science·Dong-xing CaoQiu-lei Xi
Apr 12, 2016·Journal of Cachexia, Sarcopenia and Muscle·Miguel L BatistaMarília Seelaender
Dec 20, 2014·The Journal of Nutritional Biochemistry·Hiu Yee KwanZhi-Ling Yu
Mar 26, 2016·PloS One·Luana Amorim BiondoJosé Cesar Rosa Neto
Jun 17, 2009·Current Opinion in Supportive and Palliative Care·Velia A Löbbe
Dec 12, 2013·American Journal of Physiology. Endocrinology and Metabolism·Agné KulytéIngrid Dahlman
Mar 4, 2020·Cells·Ilona RybinskaTiziana Triulzi
Jul 15, 2020·International Journal of Molecular Sciences·Michele MannelliTania Fiaschi
Jan 11, 2020·Frontiers in Oncology·Hannes ZwicklMartin Pecherstorfer
May 4, 2011·Revista do Colégio Brasileiro de Cirurgiões·Célia Sampaio CostaNelson Fontana Margarido
Jun 22, 2013·Molecular Cancer Research : MCR·Aaron LaineTej K Pandita
May 13, 2009·Current Opinion in Lipidology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Related Papers

Drug Discovery Today
Josep M ArgilésFrancisco J López-Soriano
Current Opinion in Clinical Nutrition and Metabolic Care
Christopher Deans, Stephen J Wigmore
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
Matthew J Delano, Lyle L Moldawer
Current Opinion in Supportive and Palliative Care
Josep M ArgilésFrancisco J López-Soriano
© 2022 Meta ULC. All rights reserved